Keane, J. and Bresnihan, B. (2008) Tuberculosis Reactivation during Immune Suppressive Therapy in Rheumatic Diseases: Diagnostic and Therapeutic Strategies. Current Opinion in Rheumatology, 20, 443-449. http://dx.doi.org/10.1097/BOR.0b013e3283025ec2

has been cited by the following article:

• TITLE: Tuberculous Peritonitis Mimicking Malignancy during Adalimumab Therapy in a Patient with Rheumatoid Arthritis

  AUTHORS: Refik Demirtunç, Uğur Özensoy, Kadir Kayataş, Fügen Vardar Aker

  KEYWORDS: Adalimumab, Rheumatoid Arthritis, Tuberculous Peritonitis

  JOURNAL NAME: Journal of Tuberculosis Research, Vol.3 No.3, August 27, 2015

  ABSTRACT: We present a case of tuberculous peritonitis in a 46-year-old woman with rheumatoid arthritis treated with adalimumab, and we review the association between anti-tumour necrosis factor therapy and tuberculosis. This case illustrates that tuberculosis can develop with atypical clinic and uncertain laboratory findings and may mimic malignancies during adalimumab therapy.